AJMC® in the Press, July 10, 2020

An opinion piece in The New York Times cited an article appearing in the July 2020 issue of The American Journal of Managed Care^® (AJMC^®). “The Escalation of the Opioid Epidemic Due to COVID-19 and Resulting Lessons About Treatment Alternatives” highlights factors worsening the opioid epidemic during the coronavirus disease 2019 (COVID-19) pandemic. Authors also offer an alternative approach to the opioid epidemic that can improve health and financial outcomes. An article appearing on Patch.com also mentioned the piece.

A study published in The American Journal of Accountable Care^® (AJAC) was referenced in an article published in RevCycle Intelligence. “Accountable Care Organizations and Patient-Centered Medical Homes: Health Expenditures and Health Services” appeared in the June 2020 issue of AJAC. The study compared health care costs and service utilization patterns of patients who received care from accountable care organizations, patient-centered medical homes, hybrid, and standard facilities.

A May 2019 study published in AJMC^® was referenced in a Business Insider article discussing Anthem’s pharmacy benefit manager acquiring Zipdrug, a pharmacy start-up. The study, “Potential Impact of Pharmaceutical Industry Rebates on Medication Adherence,” focused on the role of medication rebates on patients’ out-of-pocket costs and medication adherence.

An article appearing in Security Magazine referenced a May 2019 article from AJMC.com entitled “Violence Against Healthcare Workers: A Rising Epidemic.” Morale burnout, unreported attacks, and efforts to reduce acts of violence are all addressed in the AJMC^® piece. The article was also referenced in a piece from Risk & Insurance.

A study appearing in the September 2018 issue of AJMC^®, titled “High-Touch Care Leads to Better Outcomes and Lower Costs in a Senior Population,” was referenced in an article by the Santa Maria Sun. The study evaluated the impact of a high-touch primary care model among a Medicare Advantage population compared with a standard practice-based model.

An article on BioSpace.com referenced a May 2018 article appearing on AJMC.com. The article, “Can the Framingham General Cardiovascular Risk Score Accurately Predict Cognitive Decline?,” examined a study in which researchers sought to determine if the score had potential as an indicator of cognitive decline in a patient population without current diagnoses of dementia.

The Washington Examiner quoted an April 2020 article appearing on AJMC.com. The article, entitled “Caution Strongly Recommended When Using Chloroquine, Hydroxychloroquine in Patients With Cardiovascular Disease, COVID-19,” relays guidance issued from the American Heart Association, the American College of Cardiology, and the Heart Rhythm Society regarding the use of hydroxychloroquine in patients with COVID-19.

An HIV Plus Magazine piece referenced an AJMC.com article, “ART May Lower Risk of COVID-19 in Persons With HIV.” The article notes that HIV-positive individuals living in Spain who were on antiretroviral treatment (ART) with the nucleotide reverse transcriptase inhibitor backbone of tenofovir disoproxil fumarate/emtricitabine appear to have a greater ability to fight off comorbid COVID-19.

An opinion piece in The Center Square cited an August 2019 study published in AJMC^®. “Influence of Out-of-Network Payment Standards on Insurer-Provider Bargaining: California’s Experience” found that California’s implementation of a policy to address surprise medical billing demonstrated that out-of-network payment standards can influence payer-provider bargaining leverage.